Inhibiting Eph B-3 kinase
    8.
    发明授权
    Inhibiting Eph B-3 kinase 有权
    抑制Eph B-3激酶

    公开(公告)号:US08927545B2

    公开(公告)日:2015-01-06

    申请号:US13260990

    申请日:2010-03-30

    CPC分类号: A61K31/437 A61K31/00

    摘要: EphB3 kinase inhibitor compounds, including certain pyrazolo[1,5-a]pyridine and imidazo[1,2-a]pyridine compounds, inhibit EphB3 kinase. The EphB3 kinase inhibitor compounds can have greater potency for the inhibition of EphB3 kinase than general kinase inhibitors. Pharmaceutical compositions, such as neuroprotective agents, comprising the EphB3 kinase inhibitor compounds are also provided. The EphB3 kinase inhibitor compounds and pharmaceutical compositions are useful, for example, to provide neuroprotection and/or repair of neuronal tissue damaged during an ischemic event, such as a stroke.

    摘要翻译: 包括某些吡唑并[1,5-a]吡啶和咪唑并[1,2-a]吡啶化合物的EphB3激酶抑制剂化合物抑制EphB3激酶。 与一般激酶抑制剂相比,EphB3激酶抑制剂化合物对EphB3激酶的抑制作用可能更大。 还提供了包含EphB3激酶抑制剂化合物的药物组合物,例如神经保护剂。 EphB3激酶抑制剂化合物和药物组合物可用于例如在缺血事件(例如中风)期间损伤的神经元组织的神经保护和/或修复。